NEPATWIST

285.00

Better Patient Compliance/Safe in Diabetic Cataract Surgeries

Non-inferior to ketorolac 5 mg/ml in reducing inflammation & was more comfortable upon instillation./Vehicle group developed macular oedema (16.7%) compared to patients treated with Nepafenac (3.2%).

Category:

COMPOSITION

Nepafenac 0.1 % w/v Eye drops

PACKING 

5 ml

ALL INDICATIONS

In…Postoperative Pain & Inflammation Associated with Cataract Surgery & Pterygium Surgery Prevent Risk of Postoperative Macular Oedema in Diabetic Patients

For Prevention & Treatment of Pain and Inflammation : 1 drop 3 times daily beginning 1 day prior to cataract surgery continued on the day of surgery and for the first 2 weeks of the postoperative period/For the reduction in the risk of Postoperative Macular Oedema in Diabetic Patients : 1 drop 3 times daily beginning 1 day prior to cataract surgery continued on the day of surgery and up to 60 days of the postoperative period